Page last updated: 2024-10-31

metoprolol and Cross-Transfusion, Intrauterine

metoprolol has been researched along with Cross-Transfusion, Intrauterine in 1 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Research Excerpts

ExcerptRelevanceReference
"Recipients of severe twin-to-twin transfusion syndrome (TTTS) may suffer from low cardiac output caused by myocardial hypertrophy and sudden postnatal drop in preload."1.51Beta blocker therapy in recipients of twin-to-twin transfusion syndrome. ( Franz, AR; Gruendler, K; Lorenz, L; Poets, CF; Schwarz, CE, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gruendler, K1
Schwarz, CE1
Lorenz, L1
Poets, CF1
Franz, AR1

Other Studies

1 other study available for metoprolol and Cross-Transfusion, Intrauterine

ArticleYear
Beta blocker therapy in recipients of twin-to-twin transfusion syndrome.
    Archives of disease in childhood. Fetal and neonatal edition, 2019, Volume: 104, Issue:5

    Topics: Adrenergic beta-1 Receptor Antagonists; Cardiac Output, Low; Echocardiography; Female; Fetofetal Tra

2019